HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxic proliferation requires EGFR-mediated ERK activation in human pulmonary microvascular endothelial cells.

Abstract
We have previously shown that hypoxic proliferation of human pulmonary microvascular endothelial cells (hPMVECs) depends on epidermal growth factor receptor (EGFR) activation. To determine downstream signaling leading to proliferation, we tested the hypothesis that hypoxia-induced proliferation in hPMVECs would require EGFR-mediated activation of extracellular signal-regulated kinase (ERK) leading to arginase II induction. To test this hypothesis, hPMVECs were incubated in either normoxia (21% O2, 5% CO2) or hypoxia (1% O2, 5% CO2) and Western blotting was performed for EGFR, arginase II, phosphorylated-ERK (pERK), and total ERK (ERK). Hypoxia led to greater EGFR, pERK, and arginase II protein levels than did normoxia in hPMVECs. To examine the role of EGFR in these hypoxia-induced changes, hPMVECs were transfected with siRNA against EGFR or a scrambled siRNA and placed in hypoxia. Inhibition of EGFR using siRNA attenuated hypoxia-induced pERK and arginase II expression as well as the hypoxia-induced increase in viable cell numbers. hPMVECs were then treated with vehicle, an EGFR inhibitor (AG1478), or an ERK pathway inhibitor (U0126) and placed in hypoxia. Pharmacologic inhibition of EGFR significantly attenuated the hypoxia-induced increase in pERK level. Both AG1478 and U0126 also significantly attenuated the hypoxia-induced increase in viable hPMVECs numbers. hPMVECs were transfected with an adenoviral vector containing arginase II (AdArg2) and overexpression of arginase II rescued the U0126-mediated decrease in viable cell numbers in hypoxic hPMVECs. Our findings suggest that hypoxic activation of EGFR results in phosphorylation of ERK, which is required for hypoxic induction of arginase II and cellular proliferation.
AuthorsHilary A White, Yi Jin, Louis G Chicoine, Bernadette Chen, Yusen Liu, Leif D Nelin
JournalAmerican journal of physiology. Lung cellular and molecular physiology (Am J Physiol Lung Cell Mol Physiol) Vol. 312 Issue 5 Pg. L649-L656 (05 01 2017) ISSN: 1522-1504 [Electronic] United States
PMID28188223 (Publication Type: Journal Article)
CopyrightCopyright © 2017 the American Physiological Society.
Chemical References
  • Butadienes
  • Culture Media, Conditioned
  • Nitriles
  • Quinazolines
  • RNA, Small Interfering
  • Tyrphostins
  • U 0126
  • RTKI cpd
  • ErbB Receptors
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Arginase
Topics
  • Arginase (metabolism)
  • Butadienes (pharmacology)
  • Cell Count
  • Cell Hypoxia (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Culture Media, Conditioned (pharmacology)
  • Endothelial Cells (drug effects, enzymology)
  • Enzyme Activation (drug effects)
  • ErbB Receptors (metabolism)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Gene Knockdown Techniques
  • Gene Silencing (drug effects)
  • Humans
  • Lung (blood supply)
  • Microvessels (pathology)
  • Nitriles (pharmacology)
  • Phosphorylation (drug effects)
  • Quinazolines (pharmacology)
  • RNA, Small Interfering (metabolism)
  • Tyrphostins (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: